ArticleJournal of the American Heart Association2018

Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.

Xiaoxiong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.